[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/20, TUE) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 비만 'GLP-1' 효능 경쟁? "리얼월드선 달라..3가지 간과"
[https://www.biospectator.com/news/view/30099](https://www.biospectator.com/news/view/30099)

 와이바이오, '다중항체-사이토카인 융합체' 2건 SITC 발표
[https://www.biospectator.com/news/view/30123](https://www.biospectator.com/news/view/30123)

 삼성에피스, 브라질 '솔리리스 시밀러' 10년 단독공급
[https://www.biospectator.com/news/view/30125](https://www.biospectator.com/news/view/30125)

 루닛, "AZ 참여" 유방암 'HER2 초저발현' 결과 ESMO 공개
[https://www.biospectator.com/news/view/30124](https://www.biospectator.com/news/view/30124)

 유한양행, 창립 100주년 기념 ‘유한양행 100년사’ 발간
[https://www.biospectator.com/news/view/30130](https://www.biospectator.com/news/view/30130)

 로슈, 'IL-6R 항체 SC’ TED 적응증 추가 “FDA 승인"
[https://www.biospectator.com/news/view/30117](https://www.biospectator.com/news/view/30117)

 아이비스, '신규 IMiD' 파킨슨병 αSyn 억제기전 "논문"
[https://www.biospectator.com/news/view/30037](https://www.biospectator.com/news/view/30037)

 로슈, 中한소와 ‘ADC 개발’ 150억弗↑규모 “빅딜”
[https://www.biospectator.com/news/view/30127](https://www.biospectator.com/news/view/30127)

 셀트리온, 日·亞·중남미 시장서 '바이오시밀러 제품군' 확대
[https://www.biospectator.com/news/view/30132](https://www.biospectator.com/news/view/30132)

 휴온스, '경구 TG2 저해제' FSCD 비임상 결과 "UEG 발표"
[https://www.biospectator.com/news/view/30129](https://www.biospectator.com/news/view/30129)

 동아ST, 솔티드와 'AI 보행분석 솔루션' 국내 독점판매 
[https://www.biospectator.com/news/view/30133](https://www.biospectator.com/news/view/30133)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/20, TUE) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)